Global Share

STATUS Study Complete

Study of Remdesivir in Participants Below 18 Years Old With COVID-19 (CARAVAN)

OVERVIEW

A Phase 2/3 Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With COVID-19 (CARAVAN)

PROTOCOL SUMMARY

The goals of this clinical study are to learn more about the study drug, remdesivir, and how safe it is in participants less than 18 years old with coronavirus disease 2019 (COVID-19).

View More

Participation Requirements

Calendar

Age

0 - 18 Years

Condition

Sex

All

Healthy Icon

Healthy Volunteers

No

Study Details

Medical Condition

COVID-19

Gender

N/A

Date

July 2020 - February 2023

Study Type

Interventional

Study Phase

Phase 2, Phase 3

Product

Remdesivir

Eligibility Information

Inclusion

Inclusion Criteria

  • Aged < 18 years of age who meet one of the following weight criteria (where permitted according to local law and approved nationally and by relevant institutional review board (IRB) or independent ethics committee (IEC)).
  • a) Cohort 1: ≥ 12 years to < 18 years of age and weight at screening ≥ 40 kg
  • b) Cohorts 2-4: ≥ 28 days to < 18 years of age and weight at screening ≥ 3 kg and < 40 kg
  • c) Cohort 5: ≥ 14 days to < 28 days of age, gestational age > 37 weeks and weight at screening ≥ 2.5 kg
  • d) Cohort 6: 0 days to < 14 days of age, gestational age > 37 weeks and birth weight of ≥ 2.5 kg
  • e) Cohort 7: 0 days to < 56 days of age, gestational age ≤ 37 weeks and birth weight of ≥ 1.5 kg
  • f) Cohort 8: < 12 years of age and weight at screening ≥ 40 kg
  • Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection confirmed by polymerase chain reaction (PCR).
  • Hospitalized and requiring medical care for coronavirus disease 2019 (COVID-19).
VIEW MORE
Exclusion

Exclusion Criteria

  • Concurrent treatment with other agents with actual or possible direct antiviral activity against SARS-CoV-2 < 24 hours prior to study drug dosing.
  • Alanine Aminotransferase (ALT) or aspartate aminotransferase (AST) > 5 X upper limit of normal (ULN).
  • Estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73m^2 using Schwartz formula for individuals ≥ 1 year of age.
  • Creatinine above protocol specified thresholds for < 1 year of age.
  • Positive pregnancy test at Screening only for female of child bearing potential. Note: If female participants who become pregnant during the study or are discovered to be pregnant after receiving at least one dose may continue study drug, after discussion with the investigator.
  • On renal replacement therapies (intermittent hemodialysis (iHD), peritoneal dialysis (PD), continuous renal replacement therapy (CRRT)).
  • Note: Other protocol defined Inclusion/Exclusion criteria may apply
VIEW MORE

Locations

Locations (32)
Other

Children's Hospital of Alabama

Birmingham, Alabama, United States, 35233

Other

Children's Hospital Los Angeles

Los Angeles, California, United States, 90027

Other

Ronald Reagan University of California, Los Angeles Medical Center

Los Angeles, California, United States, 90095

Other

Valley Children's Hospital

Madera, California, United States, 93636

Other

UC Davis Medical center

Sacramento, California, United States, 95817

Other

Rady Children's Hospital San Diego

San Diego, California, United States, 92123

Other

Tampa General Hospital (Inpatient Visits)

Tampa, Florida, United States, 33606

Other

Ann & Robert H. Lurie Children's Hospital

Chicago, Illinois, United States, 60611

Other

Norton Children's Hospital

Louisville, Kentucky, United States, 40202

Other

Tulane University School of Medicine

New Orleans, Louisiana, United States, 70112

Other

Johns Hopkins Children's Center

Baltimore, Maryland, United States, 21287

Other

Boston Children's Hospital

Boston, Massachusetts, United States, 02115

Other

Spectrum Health/Helen De Vos Children's Hospital

Grand Rapids, Michigan, United States, 49503

Other

Children's Minnesota

Minneapolis, Minnesota, United States, 55404

Other

NYC Health + Hospitals/Jacobi Medical Center

Bronx, New York, United States, 10461

Other

Montefiore Medical Center

Bronx, New York, United States, 10467

Other

Northwell Health-Cohen Children's Medical Center

New Hyde Park, New York, United States, 11040

Other

Carolinas Medical Center-Levine Children's Hospital

Charlotte, North Carolina, United States, 28203

Other

Lehigh Valley Hospital/Lehigh Valley Health Network (LVH/LVHN)

Allentown, Pennsylvania, United States, 18103

Other

St. Christopher's Hospital for Children

Philadelphia, Pennsylvania, United States, 19134

Other

Children's Medical Center

Dallas, Texas, United States, 75235

Other

Texas Children's Hospital

Houston, Texas, United States, 77030

Other

Azienda Ospedaliero Universitaria Meyer

Florence, Italy, 50139

Other

Azienda Ospedaliera di Padova - Dipartimento Salute della Donna e del Bambino

Padova, Italy, 35128

Other

UO Clinica Pediatrica, Ospedale Pietro Barilla - AOU di Parma

Parma, Italy, 43126

Other

Hospital Universitari Vall D'Hebron

Barcelona, Spain, 8035

Other

Hospital Sant Joan de Déu

Esplugues de llobregat, Spain, 8950

Other

Hospital General Universitario Gregorio Maranon

Madrid, Spain, 28009

Other

Hospital Universitario 12 de Octubre

Madrid, Spain, 28041

Other

Hospital Universitario La Paz

Madrid, Spain, 28041

Other

Hospital Clínico Universitario de Santiago

Santiago de Compostela, Spain, 15706

Other

Alder Hey Children's NHS Foundation Trust

Liverpool, United Kingdom, L12 2AP